10620
K. A. Clayton et al. / Tetrahedron 63 (2007) 10615–10621
4.5.1.1. Ethyl 30-(400-bromophenyl)-40,60-dimethoxyin-
00
127.6 (C2 ), 129.1, 129.6 (C4 ), 130.2, 130.7 (C5 ), 131.0,
00
00
dol-20-yl-2-(O-2,4-dinitrophenoxyimino)acetate (1a). Ethyl
30-(400-bromophenyl)-40,60-dimethoxyindol-20-yl-2-(hydroxy-
imino)acetate 7a: 0.28 g, 0.63 mmol, yield: 0.29 g, 75%,
mp 214–215 ꢃC, appearance: yellow-orange solid; 1H NMR
(300 MHz, CDCl3) d 1.13–1.27 (m, 6H, CH3), 3.58–3.93
00
000
00
131.4 (C3 ), 135.9, 137.1 (C2 ), 139.0, 139.21 (C1 ),
0
139.8, 140.1 (C7a ), 140.1, 141.4 (C4 ), 149.4, 151.6 (C6 ),
000
0
0
000
155.1, 155.3 (C4 ), 156.8, 157.0 (C1 ), 160.0, 161.1
(C]N), 161.5, 173.5 (OCO); nmax 3385, 1739, 1626,
1607 cmꢁ1; lmax (CHCl3) 408 nm (3 29,000 cmꢁ1 Mꢁ1),
333 (50,000), 252 (53,000); m/z (ESI) 549 ([M+H], 9%),
365 (100), 293 (13); found: C, 58.3; H, 4.5; N, 9.9. Calcd
for C27H24N4O9$0.1CHCl3: C, 58.1; H, 4.3; N, 10.0.
0
(m, 16H, OMe, CH2), 6.15 (br s, 2H, H5 ), 6.47, 6.61 (2d,
0
00
2H, J¼1.9 Hz, H7 ), 7.26 (m, 4H, H2 ), 7.48–7.61 (m, 4H,
00
000
H3 ), 7.90, 8.23 (2d, 2H, J¼9.4 Hz, H6 ), 8.45, 8.53 (2dd,
000
2H, J¼2.6, 9.4 Hz, H5 ), 8.30, 9.12 (2d, 2H, J¼2.6 Hz,
H3 ), 8.70, 10.77 (2br s, 2H, NH); 13C NMR (75.5 MHz,
4.5.1.4. Ethyl 40,60-dimethoxy-30-(400-methoxyphenyl)-
indol-20-yl-2-(O-2,4-dinitrophenoxyimino)acetate (1e).
Ethyl 40,60-dimethoxy-30-(400-methoxyphenyl)indol-20-yl-2-
(hydroxyimino)acetate 7e: 0.78 g, 1.95 mmol, yield: 0.78 g,
000
CDCl3) d 13.5, 14.6 (CH3), 55.7, 55.8 (40-OMe), 56.1, 56.4
0
(C5 ), 106.1 (C3a ), 117.4 (C6 ), 119.7 (C3 ), 121.3, 122.2
0
(4 -OMe), 62.0, 62.7 (CH2), 86.7, 88.7 (C7 ), 93.1, 93.2
0
0
000
000
1
71%, mp 173–174 ꢃC, appearance: yellow-orange solid; H
0
(C2 ), 124.0, 125.3 (C4 ), 126.8, 127.8 (C1 ), 130.1, 130.2
00
00
00
000
00
000
(C2 ), 130.3, 130.7 (C5 ), 132.9, 133.5 (C3 ), 136.2 (C2 ),
NMR (300 MHz, CDCl3) d 1.10–1.26 (m, 6H, CH3), 3.56–
3.92 (m, 22H, 40-, 60- and 400-OMe), 6.10, 6.12 (2d, 2H,
0
139.8 (C7a ), 141.4, 141.6 (C4 ), 151.2 (C6 ), 155.6, 155.7
000
0
0
000
0
0
(C4 ), 160.1 (C1 ), 160.6, 161.9 (C]N), 165.6, 170.8 (OCO);
nmax 3382, 1738, 1626, 1606 cmꢁ1; lmax (CHCl3) 386 nm (3
16,000 cmꢁ1 Mꢁ1), 262 (23,000); m/z (ESI) 614/616 ([M+H],
4%), 429/431 (100); found: C, 42.3; H, 2.9; N, 7.5. Calcd for
C26H21BrN4O9$1.4CHCl3: C, 42.2; H, 2.9; N, 7.2.
J¼1.9 Hz, H5 ), 6.42, 6.58 (2d, 2H, J¼1.9 Hz, H7 ), 6.89 (m,
0
0
0
0
4H, H2 ), 7.30 (m, 4H, H3 ), 7.90, 8.21 (2d, 2H, J¼9.4 Hz,
000
000
H6 ), 8.39, 8.50 (2dd, 2H, J¼2.6, 9.4 Hz, H5 ), 8.87, 9.09
(2d, 2H, J¼2.6 Hz, H3 ), 8.72, 10.69 (2br s, 2H, NH); 13C
000
NMR (75.5 MHz, CDCl3) d 13.4, 13.5 (CH3), 55.0, 55.1 (40-
OMe), 55.2 (400-OMe), 55.5, 55.7 (60-OMe), 62.7, 62.8
4.5.1.2. Ethyl 30-phenyl-40,60-dimethoxyindol-20-yl-2-
(O-2,4-dinitrophenoxyimino)acetate (1c). Ethyl 30-phen-
yl-40,60-dimethoxyindol-20-yl-2-(hydroxyimino)acetate 7c:
0.37 g, 1.01 mmol, yield: 0.23 g, 43%, mp 165–166 ꢃC, ap-
pearance: yellow-orange solid; 1H NMR (300 MHz, CDCl3)
d 1.08–1.27 (m, 6H, CH3), 3.47–3.97 (m, 16H, OMe,
0
(CH2), 85.6, 85.7 (C7 ), 93.0, 93.4 (C5 ), 112.2, 112.3 (C3 ),
0
00
0
000
112.4, 113.7 (C3a ), 116.6 (C6 ), 118.0, 118.3 (C3 ), 121.9,
0
0
122.5 (C2 ), 124.9, 126.0 (C1 ), 129.0, 130.2 (C5 ), 132.2,
00
000
00
132.7 (C2 ), 135.4, 135.9 (C2 ), 139.8, 139.9 (C7a ), 141.0,
000
0
000
0
0
141.5 (C4 ), 149.4, 151.6 (C6 ), 155.3, 156.1 (C4 ), 157.0
000
00
(C1 ), 159.1, 160.2 (C4 ), 161.1, 161.2 (C]N), 161.6, 173.0
(OCO); nmax 3388, 1739, 1605 cmꢁ1; lmax (CHCl3) 333 nm
(3 7000 cmꢁ1 Mꢁ1), 248 (12,000); m/z (ESI) 565 ([M+H],
8%), 381 (100); found: C, 54.3; H, 4.4; N, 8.9. Calcd for
C21H22N2O6$0.33CHCl3: C, 54.3; H, 4.1; N, 9.3.
0
OCH2), 6.13 (br s, 2H, H5 ), 6.46, 6.61 (2d, 2H, J¼1.9 Hz,
0
00
00
00
H7 ), 7.24–7.43 (m, 10H, H2 , H3 , H4 ), 7.90, 8.23 (2d,
000
2H, J¼9.4 Hz, H6 ), 8.42, 8.52 (2dd, 2H, J¼2.6, 9.4 Hz,
000
000
H5 ), 8.30, 9.12 (2d, 2H, J¼2.6 Hz, H3 ), 8.73, 10.77 (2br
s, 2H, NH); 13C NMR (75.5 MHz, CDCl3) d 13.3, 13.4
(CH3), 55.0, 55.1 (40-OMe), 55.5, 55.7 (60-OMe), 62.7,
4.6. Preparation of indolo[2,3-c]quinolines
0
62.8 (CH2), 85.6, 85.7 (C7 ), 93.1, 93.5 (C5 ), 110.5, 112.3
0
0
(C3a ), 116.7, 116.8 (C6 ), 118.0, 118.3 (C3 ), 119.2, 119.4
000
0
4.6.1. General procedure for the formation of the tetra-
cycles 2. The appropriate cyclisation precursor 1 (1 mol
equiv) and triethylamine (10 mol equiv) in dry tetrahydrofu-
ran (42 L per mole of cyclisation precursor 1) were heated at
reflux until TLC analysis showed consumption of the start-
ing material. The solvent was then removed in vacuo and
the residue dissolved in dichloromethane whereupon it was
slowly added to 2 M hydrochloric acid resulting in precipi-
tation. The precipitate was collected and the aqueous layer
separated. The organic layer was again extracted with 2 M
hydrochloric acid and the aqueous washings and the precip-
itate combined. Dichloromethane was added to the aqueous
mixture, which was subsequently adjusted to pH 12 with con-
centrated sodium hydroxide solution, resulting in the sus-
pended solid dissolving. The organic phase was separated
and the aqueous layer was then extracted again with dichloro-
methane. The combined organic phases were dried over mag-
nesium sulfate and the solvent removed in vacuo to yield the
tetracycles 2a–e. Where necessary a small sample was re-
crystallised from chloroform for elemental analysis.
000
0
00
(C3 ), 122.0, 122.6 (C2 ), 126.8, 127.0 (C2 ), 129.1, 130.2
000
(C5 ), 131.2, 131.4 (C3 ), 132.8, 133.7 (C4 ), 135.5 (C2 ),
00
00
000
00
0
000
138.9, 139.8 (C1 ), 140.7 (C7a ), 141.6 (C4 ), 149.2, 151.5
0
0
000
(C4 ), 155.1, 155.3 (C6 ), 156.0, 156.1 (C1 ), 160.1, 161.3
(C]N), 161.4, 173.3 (OCO); nmax 3380, 1726, 1624,
1608 cmꢁ1; lmax (CHCl3) 385 nm (3 16,000 cmꢁ1 Mꢁ1),
257 (23,000); m/z (ESI) 535 ([M+H], 9%), 451 (6), 351
(100), 279 (6); found: C, 57.2; H, 4.5; N, 9.9. Calcd for
C26H22N4O9$0.125CHCl3: C, 57.1; H, 4.1; N, 10.2.
4.5.1.3. Ethyl 40,60-dimethoxy-30-(400-methylphenyl)-
indol-20-yl-2-(O-2,4-dinitrophenoxyimino)acetate (1d).
Ethyl 40,60-dimethoxy-30-(400-methylphenyl)indol-20-yl-2-
(hydroxyimino)acetate 7d: 1.01 g, 2.65 mmol, yield:
1.07 g, 74%, mp 170–171 ꢃC, appearance: yellow-orange
1
solid; H NMR (300 MHz, CDCl3) d 1.09–1.27 (m, 6H,
CH3), 2.40 (s, 6H, 400-Me), 3.50–3.95 (m, 16H, OMe,
0
CH2), 6.11, 6.14 (2d, 2H, J¼1.5 Hz, H5 ), 6.44, 6.60 (2d,
0
00
00
2H, J¼1.5 Hz, H7 ), 7.14–7.31 (m, 8H, H2 , H3 ), 7.90,
000
8.23 (2d, 2H, J¼9.4 Hz, H6 ), 8.41, 8.52 (2dd, 2H, J¼2.6,
000
000
9.4 Hz, H5 ), 8.83, 9.11 (2d, 2H, J¼2.6 Hz, H3 ), 8.71,
10.73 (2br s, 2H, NH); 13C NMR (75.5 MHz, CDCl3)
d 13.3, 13.4 (CH3),0 21.1, 21.2 (400-Me), 55.0, 55.1 (40-
4.6.1.1. Ethyl 3-bromo-9,11-dimethoxy indolo[2,3-c]-
quinoline-6-carboxylate (2a). Ethyl 30-(400-bromophenyl)-
40,60-dimethoxyindol-20-yl-2-(O-2,4-dinitrophenoxyimino)-
acetate 1a: 0.0503 g, 0.082 mmol, yield: 0.033 g, 94%, mp
199–200 ꢃC, appearance: yellow-orange solid; 1H NMR
(300 MHz, CDCl3) d 1.24 (t, 3H, J¼7.2 Hz, CH3), 3.95,
0
OMe), 55.5, 55.7 (6 -OMe), 62.6, 62.8 (CH2), 85.7 (C7 ),
0
93.0, 93.4 (C5 ), 113.5, 113.6 (C3a ), 116.6 (C6 ), 118.0,
0
000
0
00
118.3 (C3 ), 119.3, 119.5 (C3 ), 121.9, 122.5 (C2 ), 127.5,
0